|Generate QR code
Open Access
Subscription Access
Clinical and genealogical criteria for intestinal tumors
https://doi.org/10.29235/1818-9857-2023-08-76-83
Abstract
Difficulties in timely diagnosis, the high cost and complexity of treatment, as well as the high mortality rate of malignant neoplasms determine the relevance of combating them. The highest cumulative incidence of colon cancer is observed in the industrial centers of the region. Primary multiple tumors and breast cancer in men are found with a high frequency. The role of the Amsterdam Criteria in the diagnosis of hereditary non-polyposis colon cancer in the region is limited. The risk of developing colon cancer of hereditary genesis is present in 0,49% of the region's population. The proposed criteria for the formation of risk groups are adequate and convenient for oncogenetic counseling.
About the Author
O. Kuznetsov
Институт биохимии биологически активных соединений НАН Беларуси; Гродненский государственный медицинский университет
Belarus
Belarus
Oleg Kuznetsov
References
1. F. Bray [et al.]. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA: A Cancer Journal for Clinicians. 2018. Vol. 68. №6. P. 394–424.
2. О. Е. Кузнецов, В. М. Цыркунов. Вирус-ассоциированный гепатоцеллюлярный рак печени // Гепатология и гастроэнтерология. 2021. Т. 5. №1. С. 17–24.
3. F. Bray. Global Cancer Statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA: A Cancer Journal for Clinicians, in press. The online GLOBOCAN 2018 database is accessible at http://gco.iarc.fr/, as part of IARC’s Global Cancer Observatory.
4. Приказ Мин-ва здравоохранения Респ. Беларусь №1018 27.12.2007 №1018 ≪Об онкогенетическом консультировании≫. – Минск, 2009.
5. Статистика злокачественных новообразований в России и странах СНГ в 2004 г. / под ред. М. И. Давыдова, Е. А. Аксель // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2006. Т. 17. №3 (прил. 1).
6. Информационная система учета и мониторинга онкологических заболеваний: пат. №675 Респ. Беларусь / О. Е. Кузнецов; заявитель Кузнецов О. Е. – С20140041; опубл. 20.06.2014 // Афiцыйны бюл. / Нац. цэнтр iнтэлектуал. уласнасцi.
7. Океанов А. Е. [и др.]. Статистика онкологических заболеваний в Республике Беларусь (2008–2017) / А. Е. Океанов, П. И. Моисеев, Л. Ф. Левин, под ред. О. Г. Суконко // Министерство здравоохранения Республики Беларусь, ГУ ≪Республиканский научно-практический центр онкологии и медицинской радиологии им. Н. Н. Александрова≫. – Минск, 2018.
8. A. Meindl [et al.]. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts // Deutsches Arzteblatt International. 2011. Vol. 108(19). P. 323–330.
9. H. T. Lynch, J. F. Lynch, T. G. Shaw [et al.]. HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management // Review. Hereditary Cancer in Clinical Practice. 2003. Vol. 1. P. 7. https://doi.org/10.1186/1897–4287–1–1–7.
10. L. Rabeneck [et al.]. Ontario's Colon Cancer Check: results from Canada's first province-wide colorectal cancer screening program // Oncology. Ontario. 2014. №23(3). P. 508–515.
11. Hyuna Sung [et al.]. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // American Cancer Society. CA: A Cancer Journal for Clinicians. 2021. №71. P. 209–249.
12. M. Gerstung, C. Jolly, I. Leshchiner [et al]. The evolutionary history of 2,658 cancers // Nature. 2020. №578. P. 122–128. https://doi.org/10.1038/s41586–019–1907–7.
13. A. Umar, C. Boland, J. Terdiman [at al]. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability // Journal of the National Cancer Institute. 2004. Vol. 96. P. 261–268.
Review
For citations:
Kuznetsov O. Clinical and genealogical criteria for intestinal tumors. Science and Innovations. 2023;(8):76-83. (In Russ.) https://doi.org/10.29235/1818-9857-2023-08-76-83
Views: 1185
Email this article 